Drugs / SLV354
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01545310 | May 2011 → Jul 2012 | schizophrenia | Abbott | Completed | No outcome recorded |
| Phase 1 | NCT01133574 | Feb → Jul 2010 | cognitive disorder | Abbott | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SLV354 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01133574 ↗ |
| Route | Oral | “After Oral Dose Administration” NCT01133574 ↗ |